Drug factory · FDA FEI 3009057557

Orient Pharma Co., Ltd. Yunlin Plant

No. 8, Kehu 1st Rd., Huwei Township, Yunlin County, Taiwan

Taiwan: 1

No problems found at FDA's last inspection, May 23, 2025.

No Action Indicated: inspectors found no objectionable conditions.

4 drug inspections on record since 2012: 3 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
CarisoprodolMakes it Orient Pharma Co., Ltd. 76333-135
EzetimibeMakes it Orient Pharma Co., Ltd. 76333-170
GlyburideMakes it Orient Pharma Co., Ltd. 76333-154, 76333-155, 76333-156
MiglitolMakes it Orient Pharma Co., Ltd., Westminster Pharmaceuticals, LLC 76333-125, 76333-126, 76333-127 +3
PitavastatinMakes it Teva Pharmaceuticals, Inc. 0480-3631, 0480-3632, 0480-3633
TofacitinibMakes it, tests it, packages it and labels it Exelan Pharmaceuticals, Inc., Orient Pharma Co., Ltd. 76282-816, 76333-111
VancomycinMakes it, tests it, packages it and labels it Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., Orient Pharma Co., Ltd. 23155-967, 23155-968, 76333-264 +1

FDA inspection history

EndedResultProgramProblems noted
May 23, 2025No problems foundDrug Quality Assurance—
Nov 16, 2018No problems foundDrug Quality Assurance—
Apr 3, 2015Problems found, fixed voluntarilyDrug Quality Assurance—
Dec 14, 2012No problems foundDrug Quality Assurance—

Registered with FDA for: analysis; label; manufacture; pack.